Trial Profile
A Study to Evaluate the Efficacy of Once-Monthly Formulation of Risedronic Acid for the Treatment of Osteoporosis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoporosis
- Focus Registrational; Therapeutic Use
- Sponsors Ajinomoto; Takeda
- 25 Mar 2010 New trial record